1. Institute of Medicine (US) Committee on Advancing Pain Research, Care, and Education (2011) Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. National Academies Press, Washington DC.
2. The opioid epidemic and national guidelines for opioid therapy for chronic noncancer pain: a perspective from different continents
3. Low-Dose Naltrexone (LDN)—Review of Therapeutic Utilization
4. Parkitny, L. and Younger, J. (2015) Reduced Pro-Inflammatory Cytokines after Eight Weeks of Low-Dose Naltrexone for Fibromyalgia. Biomedicines, 3, 294-304.
5. Kariv, R., Tiomny, E., Grenshpon, R., Dekel, R., Waisman, G. and Ringel, Y. (2006) Low-Dose Naltrexone for the Treatment of Irritable Bowel Syndrome: A Pilot Randomized, Double-Blind, Placebo-Controlled Trial. Pain Practice, 6, 98-105.